Cervical Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Cervical Cancer, including details on symptoms, vaccine, screening, treatment, human papilloma virus (hpv), information.

Volume 5 (2008), Issue 5 (May)

1. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study.
   Lancet Oncol, 9(5): 425-34. [Abstract] [Full-text]
2. Inadequate screening in patients evaluated by nongynecologists for cervical cancer: a case control analysis.
   Am J Obstet Gynecol, 198(5): e48-50. [Abstract] [Full-text]
3. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
   J Natl Cancer Inst, 100(9): 622-9. [Abstract] [Full-text]
4. Human papillomavirus and cervical disease in adolescents.
   Clin Obstet Gynecol, 51(2): 290-305. [Abstract] [Full-text]
5. Prevalence of type-specific HPV infection by age and grade of cervical cytology: data from the ARTISTIC trial.
   Br J Cancer, 98(10): 1704-9. [Abstract] [Full-text]
6. Combined intensity-modulated radiation therapy and brachytherapy in the treatment of cervical cancer.
   Int J Radiat Oncol Biol Phys, 71(2): 618-24. [Abstract] [Full-text]
7. Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer.
   Int J Radiat Oncol Biol Phys, 71(2): 428-34. [Abstract] [Full-text]
8. DEK overexpression in uterine cervical cancers.
   Pathol Int, 58(6): 378-82. [Abstract] [Full-text]
9. Histologic results of para-aortic lymphadenectomy in patients treated for stage IB2/II cervical cancer with negative [18F]fluorodeoxyglucose positron emission tomography scans in the para-aortic area.
   J Clin Oncol, 26(15): 2558-61. [Abstract] [Full-text]
10. Patients with negative cervical biopsies after papanicolaou test interpretations of "atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion": comparative longitudinal follow-up.
    Ann Diagn Pathol, 12(3): 187-90. [Abstract] [Full-text]
11. Polymorphisms in 9q32 and TSCOT are linked to cervical cancer in affected sib-pairs with high mean age at diagnosis.
    Hum Genet, 123(5): 437-43. [Abstract] [Full-text]
12. A combination of serum tumor markers identifies high-risk patients with early-stage squamous cervical cancer.
    Tumour Biol, 29(1): 9-17. [Abstract] [Full-text]
13. Early growth response-1 mediates downregulation of telomerase in cervical cancer.
    Cancer Sci, 99(7): 1401-6. [Abstract] [Full-text]

© 2004-2010 Cervical Cancer Research Today. All Rights Reserved.